Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does OCTREOTIDE Cause Incorrect dose administered? 648 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 648 reports of Incorrect dose administered have been filed in association with OCTREOTIDE (Octreotide Acetate). This represents 2.7% of all adverse event reports for OCTREOTIDE.

648
Reports of Incorrect dose administered with OCTREOTIDE
2.7%
of all OCTREOTIDE reports
111
Deaths
257
Hospitalizations

How Dangerous Is Incorrect dose administered From OCTREOTIDE?

Of the 648 reports, 111 (17.1%) resulted in death, 257 (39.7%) required hospitalization, and 29 (4.5%) were considered life-threatening.

Is Incorrect dose administered Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for OCTREOTIDE. However, 648 reports have been filed with the FAERS database.

What Other Side Effects Does OCTREOTIDE Cause?

Death (3,801) Diarrhoea (3,621) Fatigue (2,933) Blood pressure increased (2,799) Needle issue (2,740) Malaise (2,737) Pain (2,366) Blood pressure systolic increased (2,340) Malignant neoplasm progression (2,306) Nausea (2,294)

What Other Drugs Cause Incorrect dose administered?

TIRZEPATIDE (23,301) ADALIMUMAB (14,000) DUPILUMAB (9,907) RANITIDINE (9,337) INSULIN LISPRO (8,318) ACETAMINOPHEN (5,316) DULAGLUTIDE (5,207) SECUKINUMAB (4,524) INSULIN GLARGINE (3,070) SOMATROPIN (2,772)

Which OCTREOTIDE Alternatives Have Lower Incorrect dose administered Risk?

OCTREOTIDE vs OCTREOTIDE\OCTREOTIDE OCTREOTIDE vs ODEVIXIBAT OCTREOTIDE vs OFATUMUMAB OCTREOTIDE vs OFLOXACIN OCTREOTIDE vs OLANZAPINE

Related Pages

OCTREOTIDE Full Profile All Incorrect dose administered Reports All Drugs Causing Incorrect dose administered OCTREOTIDE Demographics